Cargando…
Can MASCC and CISNE scores predict delays of lung cancer chemotherapy after febrile neutropenia?
BACKGROUND: Febrile neutropenia (FN) during cancer chemotherapy can lead to morbidity and mortality. The Multinational Association of Supportive Care in Cancer (MASCC) and clinical index of stable febrile neutropenia (CISNE) scores have been widely used to predict the risk of severe medical complica...
Autores principales: | Ono, Yoshitaka, Hayama, Naoki, Hattori, Shigeaki, Ito, Yoko, Oguma, Tsuyoshi, Sakamaki, Fumio, Asano, Koichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750814/ https://www.ncbi.nlm.nih.gov/pubmed/36330990 http://dx.doi.org/10.1111/1759-7714.14720 |
Ejemplares similares
-
Use of MASCC score in the inpatient management of febrile neutropenia: a single-center retrospective study
por: Bhardwaj, Prarthna V., et al.
Publicado: (2021) -
Asthma exacerbation associated with COVID-19 pneumonia
por: Ono, Yoshitaka, et al.
Publicado: (2021) -
Emerging challenges in the evaluation of fever in cancer patients at risk of febrile neutropenia in the era of COVID-19: a MASCC position paper
por: Cooksley, Tim, et al.
Publicado: (2020) -
Validation of the Clinical Index of Stable Febrile Neutropenia (CISNE) model in febrile neutropenia patients visiting the emergency department. Can it guide emergency physicians to a reasonable decision on outpatient vs. inpatient treatment?
por: Moon, Hae, et al.
Publicado: (2018) -
A prospective, real-world, multinational study of febrile neutropenia (FN) occurrence in oncology patients receiving chemotherapy with intermediate risk of FN: a MASCC Neutropenia, Infection, and Myelosuppression Study Group initiative
por: Leon Rapoport, Bernardo, et al.
Publicado: (2023)